SIGN UPLog In

General

Financials

People

Activity

Recent News
BOYDSense
BOYDSense
Company

Last deal

$7.59M
Local Amount - EUR 7M

Amount

Venture - Series Unknown

Stage

05.04.2024

Date

2

all rounds

$10.41M

Total amount

date founded

Financing round

General

About Company
BOYDSense develops non-invasive tools to measure critical biomarkers via exhaled breath.

Related to

Alpha MOS
Alpha MOS
Alpha MOS

Alpha MOS

Alpha MOS is a company that develops sensor technologies to digitize human senses, such as smell, taste, and vision.

Sector

Electronic and Electrical Equipment

Subsector

Gauges and Meters

Location

Toulouse, France

total rounds

1

total raised

$3.16M

count Of Investments

1

Industry

Sector :

Subsector :

founded date

01.01.2015

Number of employees

11-50

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company focuses on breath-based metabolomics to diagnose and monitor chronic diseases, starting with diabetes, using their device named Lassie. Lassie measures volatile organic compound (VOC) biomarkers in exhaled breath, making it easier and painless for people to monitor their blood glucose levels throughout the day. BOYDSense's mission is to democratize health-monitoring devices to improve people's lives, with their latest performance data showing scientifically proven results.
Contacts

location

South San Francisco, CA, USA

Contact Email

Website URL

https://www.boydsense.com/company/

Social url

Legal Names

Legal name

BoydSense SAS
Similar Companies
1000
Revelar
RevelarThe company has developed a medical technology that measures aldehydes in breath to prevent, detect, and personalize disease treatments.
Revelar

Revelar

The company has developed a medical technology that measures aldehydes in breath to prevent, detect, and personalize disease treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical Device

Location

Lake Oswego, OR, USA
NOVIOSENSE
NOVIOSENSENovioSense is a company that has developed a non-invasive glucose monitoring device to free diabetics from the painful finger prick.
NOVIOSENSE

NOVIOSENSE

NovioSense is a company that has developed a non-invasive glucose monitoring device to free diabetics from the painful finger prick.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Medical Device, Biotechnology

Location

Nijmegen, Netherlands

total rounds

2

total raised

$1.98M
Innovosens
InnovosensInnovosens develops glucose sensing devices for diabetics.
Innovosens

Innovosens

Innovosens develops glucose sensing devices for diabetics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Fitness, Wellness

Location

Malmö, Sweden
Biosense
BiosenseBiosense is a medical engineering and design firm that develops revolutionary diagnostics.
Biosense

Biosense

Biosense is a medical engineering and design firm that develops revolutionary diagnostics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology

Location

Thane, Maharashtra, India

total rounds

3

total raised

$1.5M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$10.41M

Money Raised

Their latest funding was raised on 05.04.2024. Their latest investor Alpha MOS. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
05.04.2024
Venture - Series Unknown
7
$7.59M
Local Amount - EUR 7M
Swiss Diabetes Venture Fund
Swiss Diabetes Venture Fund
06.01.2022
Grant
1
$2.82M
Local Amount - EUR 2.5M
European Innovation Council
European Innovation Council
Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund is Europe's first diabetes technology-focused venture fund.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital

Location

Lausanne, Switzerland

count Of Investments

4
European Innovation Council

European Innovation Council

The EIC pilot supports innovators and entrepreneurs by providing funding, advice, and networking opportunities for cutting-edge innovation.

Sector

Media

Subsector

Media Agencies

Keywords

Consulting

Location

Brussels, Belgium

count Of Investments

1179

count Of Exists

5
Co-Investors
Investors
7
2

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
Alpha MOS
Alpha MOS
No
Venture - Series Unknown
—
BioSerenity
BioSerenity
No
Venture - Series Unknown
—
Ambrosia Investments
Ambrosia Investments
No
Venture - Series Unknown
—
Alpha MOS

Alpha MOS

Alpha MOS is a company that develops sensor technologies to digitize human senses, such as smell, taste, and vision.

Sector

Electronic and Electrical Equipment

Subsector

Gauges and Meters

Location

Toulouse, France

total rounds

1

total raised

$3.16M

count Of Investments

1
BioSerenity

BioSerenity

BioSerenity is a medical device company focused on developing smart healthcare solutions.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Paris, France

total rounds

7

total raised

$111.47M

count Of Investments

1
Ambrosia Investments

Ambrosia Investments

Ambrosia Investments provides growth capital for disruptive brands in the food, beverage, and ingredients industries.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Food and Beverage

Location

Luxembourg District, Luxembourg

count Of Investments

6

People

Employee Profiles
4
Joel Rabasco
Joel Rabasco

Joel Rabasco

Chief Product Officer

Chief Product Officer

Arnaud Debains
Arnaud Debains

Arnaud Debains

Managing Director

Managing Director

Bruno Thuillier
Bruno Thuillier

Bruno Thuillier

CEO

CEO

Sandrine Isz
Sandrine Isz

Sandrine Isz

CSO

CSO

Activity

Recent News
0